Education
About Us
Working with TipRanks
Follow Us
Tilray (TLRY)
NASDAQ:TLRY
TLRY Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.44 - $2.52
Previous CloseN/A
Volume22.72M
Average Volume (3M)32.69M
Market Cap
$508.68M
Enterprise Value$735.46M
Total Cash (Recent Filing)C$64.47K
Total Debt (Recent Filing)C$0.00
Price to Earnings (P/E)―
Beta1.15
Next Earnings
Jul 23, 2025EPS Estimate
-0.02Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.05
Shares Outstanding1,006,495,900
10 Day Avg. Volume24,128,707
30 Day Avg. Volume32,688,898
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.73
Price to Cash Flow (P/CF)-3.70
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$0.98Price Target Upside100.00% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering7
---
Bulls Say, Bears Say
Bulls Say
Financial PerformanceAdj. EBITDA of $9M came in higher vs. our $6.5M estimate, in part from better-than-expected Canadian cannabis gross margins of 40.5%.
Growth InitiativesThe company recently completed capital investments in a facility that allows better use of byproducts for vapes and infused pre-rolls, expected to improve Canadian adult-use trends.
International ExpansionTilray's international businesses are positioned for imminent growth, with expectations for the international cannabis topline to accelerate.
Bears Say
Market ChallengesThe path to federal legalization of cannabis in the U.S. remains unclear, impacting future prospects.
Price CompetitionCanadian adult-use will be challenging due to price competition.
Sales OutlookManagement lowered their FY25 sales outlook by $50M to $850M-$900M owing to SKU rationalization efforts.
---
Ownership Overview
0.61% Insiders
0.41% Mutual Funds
2.35% Other Institutional Investors
93.16% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
TLRY FAQ
What was Tilray’s price range in the past 12 months?
Tilray lowest stock price was $0.44 and its highest was $2.52 in the past 12 months.
What is Tilray’s market cap?
Tilray’s market cap is $508.68M.
When is Tilray’s upcoming earnings report date?
Tilray’s upcoming earnings report date is Jul 23, 2025 which is in 101 days.
How were Tilray’s earnings last quarter?
Tilray released its earnings results on Apr 08, 2025. The company reported -$0.87 earnings per share for the quarter, missing the consensus estimate of -$0.044 by -$0.826.
Is Tilray overvalued?
According to Wall Street analysts Tilray’s price is currently Undervalued.
Does Tilray pay dividends?
Tilray does not currently pay dividends.
What is Tilray’s EPS estimate?
Tilray’s EPS estimate is -0.02.
How many shares outstanding does Tilray have?
Tilray has 1,006,495,900 shares outstanding.
What happened to Tilray’s price movement after its last earnings report?
Tilray reported an EPS of -$0.87 in its last earnings report, missing expectations of -$0.044. Following the earnings report the stock price went down -20.69%.
Which hedge fund is a major shareholder of Tilray?
Currently, no hedge funds are holding shares in TLRY
---
Tilray Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$0.98 (100.00% Upside)
$0.98 (100.00% Upside)
Blogger Sentiment
Bullish
TLRY Sentiment 75%
Sector Average 69%
Sector Average 69%
Hedge Fund Trend
Increased
By 1.7M Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $35.4K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 2.1%
Last 30 Days ▼ 2.4%
Last 30 Days ▼ 2.4%
News Sentiment
Very Bearish
Bullish news 0%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-74.36%
12-Months-Change
Fundamentals
Return on Equity
-31.06%
Trailing 12-Months
Asset Growth
-19.22%
Trailing 12-Months
Company Description
Tilray
Tilray Inc. (NASDAQ: TLRY) is a leading global cannabis-lifestyle and consumer packaged goods company with operations in Canada, the United States, Europe, Australia, and Latin America. The company is engaged in the research, cultivation, production, and distribution of medical cannabis and cannabinoid-based products. Tilray offers a diverse range of products across several categories, including medical and adult-use cannabis, hemp-based foods, and alcoholic beverages.
---
TLRY Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call presented both positive and negative aspects. While there were notable improvements in cannabis gross margins and international growth, significant challenges remain, particularly with net revenue decline and a substantial net loss due to non-cash impairment. The beverage segment showed mixed results with some areas of growth, but overall sales volumes faced challenges.Read More>---
TLRY Stock 12 Month Forecast
Average Price Target
$0.98
▲(100.00% Upside)
Technical Analysis
Best Analysts Covering TLRY
1 Year
1 Year Success Rate
0/6 ratings generated profit
1 Year Average Return
-65.90%
reiterated a buy rating 4 days ago
Copying Robert Moskow's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -65.90% per trade.
---